Chemours (NYSE:CC) Sets New 1-Year High - Should You Buy?

Chemours Co. shares reached a new 52-week high of $23.20, supported by UBS raising its price target to $29 despite mixed analyst sentiment and negative net margins. The company beat EPS expectations but currently offers a 1.5% dividend yield.